These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 21540443)

  • 1. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.
    Porter PL; El-Bastawissi AY; Mandelson MT; Lin MG; Khalid N; Watney EA; Cousens L; White D; Taplin S; White E
    J Natl Cancer Inst; 1999 Dec; 91(23):2020-8. PubMed ID: 10580027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
    Rayson D; Payne JI; Abdolell M; Barnes PJ; MacIntosh RF; Foley T; Younis T; Burns A; Caines J
    Clin Breast Cancer; 2011 Mar; 11(1):27-32. PubMed ID: 21421519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors.
    Collett K; Stefansson IM; Eide J; Braaten A; Wang H; Eide GE; Thoresen SØ; Foulkes WD; Akslen LA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1108-12. PubMed ID: 15894660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors contributing to mammography failure in women aged 40-49 years.
    Buist DS; Porter PL; Lehman C; Taplin SH; White E
    J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor characteristics in screen-detected and symptomatic breast cancers.
    Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z
    Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
    Holloway CMB; Jiang L; Whitehead M; Racz JM; Groome PA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1769-1775. PubMed ID: 29909564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between mammographic breast density and breast cancer tumor characteristics.
    Aiello EJ; Buist DS; White E; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prognostic value of screen detection in invasive breast cancer.
    Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
    J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
    Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
    Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.